{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:31:30Z","timestamp":1775190690589,"version":"3.50.1"},"reference-count":46,"publisher":"The Endocrine Society","issue":"11","funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["292538"],"award-info":[{"award-number":["292538"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["250114"],"award-info":[{"award-number":["250114"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sigrid Juselius Foundation"},{"DOI":"10.13039\/100010129","name":"Maud Kuistila Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010114","name":"Yrj\u00f6 Jahnsson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010114","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Diabetes Research Foundation in Finland"},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["4-1998-274"],"award-info":[{"award-number":["4-1998-274"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["4-1999-731"],"award-info":[{"award-number":["4-1999-731"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["4-2001-435"],"award-info":[{"award-number":["4-2001-435"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011104","name":"Fifth Framework Programme","doi-asserted-by":"publisher","award":["BMH4-CT98-3314"],"award-info":[{"award-number":["BMH4-CT98-3314"]}],"id":[{"id":"10.13039\/100011104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Campbell Foundation"},{"DOI":"10.13039\/501100011797","name":"Turun Yliopistollinen Keskussairaala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Characterization of slow progression to type 1 diabetes (T1D) may reveal novel means for prevention of T1D. Slow progressors might carry natural immunomodulators that delay \u03b2-cell destruction and mediate preservation of \u03b2-cell function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To identify demographic, genetic, and immunological characteristics of slow progression from seroconversion to clinical T1D.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>HLA-susceptible children (n = 7410) were observed from birth for islet cell antibody (ICA), insulin autoantibody (IAA), glutamic acid decarboxylase (GADA), and islet antigen-2 autoantibodies (IA-2A), and for clinical T1D. Disease progression that lasted \u22657.26 years (slowest) quartile from initial seroconversion to diagnosis was considered slow. Autoantibody and genetic characteristics including 45 non-HLA single nucleotide polymorphisms (SNPs) predisposing to T1D were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>By the end of 2015, 1528 children (21%) had tested autoantibody positive and 247 (16%) had progressed to T1D. The median delay from seroconversion to diagnosis was 8.7 years in slow (n = 62, 25%) and 3.0 years in other progressors. Compared with other progressors, slow progressors were less often multipositive, had lower ICA and IAA titers, and lower frequency of IA-2A at seroconversion. Slow progressors were born more frequently in the fall, whereas other progressors were born more often in the spring. Compared with multipositive nonprogressors, slow progressors were younger, had higher ICA titers, and higher frequency of IAA and multiple autoantibodies at seroconversion. We found no differences in the distributions of non-HLA SNPs between progressors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We observed differences in autoantibody characteristics and the season of birth among progressors, but no characteristics present at seroconversion that were specifically predictive for slow progression.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2019-01069","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T13:06:10Z","timestamp":1563368770000},"page":"5585-5594","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk"],"prefix":"10.1210","volume":"104","author":[{"given":"Petra M","family":"P\u00f6ll\u00e4nen","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"},{"name":"Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Lempainen","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory, Institute of Biomedicine, University of Turku and Clinical Microbiology, Turku University Hospital, Turku, Finland"},{"name":"Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti-Pekka","family":"Laine","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory, Institute of Biomedicine, University of Turku and Clinical Microbiology, Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland"},{"name":"Institute of Biomedicine and Centre for Population Health Research, University of Turku, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta","family":"Veijola","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, PEDEGO Research Group, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-2062","authenticated-orcid":false,"given":"Jorma","family":"Ilonen","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory, Institute of Biomedicine, University of Turku and Clinical Microbiology, Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heli","family":"Siljander","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"},{"name":"Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-0033","authenticated-orcid":false,"given":"Mikael","family":"Knip","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"},{"name":"Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland"},{"name":"Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland"},{"name":"Folkh\u00e4lsan Research Center, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"key":"2019101003033158400_bib1","first-page":"6","article-title":"Natural course of preclinical type 1 diabetes","volume":"57","author":"Knip","year":"2002","journal-title":"Horm Res"},{"issue":"10","key":"2019101003033158400_bib2","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1210\/jc.2002-020018","article-title":"Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population","volume":"87","author":"Kimpim\u00e4ki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019101003033158400_bib3","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2004-1371","article-title":"Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population","volume":"90","author":"Kukko","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019101003033158400_bib4","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2337\/dc09-1040","article-title":"Prediction of type 1 diabetes in the general population","volume":"33","author":"Knip","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"2019101003033158400_bib5","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00125-017-4258-7","article-title":"Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility","volume":"60","author":"P\u00f6ll\u00e4nen","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"2019101003033158400_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s001250051616","article-title":"Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort","volume":"44","author":"Kupila","year":"2001","journal-title":"Diabetologia"},{"issue":"12","key":"2019101003033158400_bib7","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2337\/db08-1305","article-title":"Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population","volume":"58","author":"Siljander","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"2019101003033158400_bib8","first-page":"870","article-title":"Triple-label hybridization assay for type-1 diabetes-related HLA alleles","volume":"18","author":"Sj\u00f6roos","year":"1995","journal-title":"Biotechniques"},{"issue":"12","key":"2019101003033158400_bib9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1464-5491.1999.00186.x","article-title":"Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci","volume":"16","author":"Nejentsev","year":"1999","journal-title":"Diabet Med"},{"issue":"2","key":"2019101003033158400_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1034\/j.1399-0039.2003.00071.x","article-title":"HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families","volume":"62","author":"Hermann","year":"2003","journal-title":"Tissue Antigens"},{"key":"2019101003033158400_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2015.05.005","article-title":"Non-HLA gene effects on the disease process of type 1 diabetes: from HLA susceptibility to overt disease","volume":"61","author":"Lempainen","year":"2015","journal-title":"J Autoimmun"},{"issue":"1","key":"2019101003033158400_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/tan.12143","article-title":"Transmission disequilibrium analysis of 31 type 1 diabetes susceptibility loci in Finnish families","volume":"82","author":"Laine","year":"2013","journal-title":"Tissue Antigens"},{"key":"2019101003033158400_bib13","unstructured":"P\u00f6ll\u00e4nen PM , LempainenJ, LaineA-P, ToppariJ, VeijolaR, IlonenJ, SiljanderH, KnipM. Data from: Characteristics of slow progression to type 1 diabetes in children with increased HLA-conferred disease risk. figshare 2019. Deposited 28 June 2019. https:\/\/doi.org\/10.6084\/m9.figshare.8088623.v2"},{"issue":"6","key":"2019101003033158400_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"issue":"26","key":"2019101003033158400_bib15","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","article-title":"Shared and distinct genetic variants in type 1 diabetes and celiac disease","volume":"359","author":"Smyth","year":"2008","journal-title":"N Engl J Med"},{"key":"2019101003033158400_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nat Genet"},{"issue":"7314","key":"2019101003033158400_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nature09386","article-title":"A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk","volume":"467","author":"Heinig","year":"2010","journal-title":"Nature"},{"issue":"7145","key":"2019101003033158400_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"issue":"12","key":"2019101003033158400_bib19","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ng.249","article-title":"Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci","volume":"40","author":"Cooper","year":"2008","journal-title":"Nat Genet"},{"issue":"11","key":"2019101003033158400_bib20","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2337\/db11-0638","article-title":"FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection","volume":"60","author":"Smyth","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"2019101003033158400_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gene.2012.01.089","article-title":"LADA and T1D in Estonian population\u2014two different genetic risk profiles","volume":"497","author":"Kisand","year":"2012","journal-title":"Gene"},{"issue":"9","key":"2019101003033158400_bib22","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00125-009-1438-0","article-title":"Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk","volume":"52","author":"Achenbach","year":"2009","journal-title":"Diabetologia"},{"issue":"7892","key":"2019101003033158400_bib23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","article-title":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies","volume":"2","author":"Bottazzo","year":"1974","journal-title":"Lancet"},{"issue":"5","key":"2019101003033158400_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1006\/jaut.1997.0154","article-title":"A novel micro-assay for insulin autoantibodies","volume":"10","author":"Williams","year":"1997","journal-title":"J Autoimmun"},{"issue":"4","key":"2019101003033158400_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s001250050925","article-title":"IA-2 antibodies\u2014a sensitive marker of IDDM with clinical onset in childhood and adolescence","volume":"41","author":"Savola","year":"1998","journal-title":"Diabetologia"},{"issue":"11","key":"2019101003033158400_bib26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s001250051067","article-title":"Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children","volume":"41","author":"Savola","year":"1998","journal-title":"Diabetologia"},{"key":"2019101003033158400_bib27","volume-title":"Definition, diagnosis and classification of diabetes mellitus and its complications.","author":"World Health Organization (WHO), Department of Noncommunicable Disease Surveillance","year":"1999"},{"key":"2019101003033158400_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"23","key":"2019101003033158400_bib29","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"2019101003033158400_bib30","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2337\/db13-0300","article-title":"Patterns of \u03b2-cell autoantibody appearance and genetic associations during the first years of life","volume":"62","author":"Ilonen","year":"2013","journal-title":"Diabetes"},{"issue":"9680","key":"2019101003033158400_bib31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study","volume":"373","author":"Patterson","year":"2009","journal-title":"Lancet"},{"key":"2019101003033158400_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2016.05.010","article-title":"Predictors of slow progression to diabetes in children with multiple islet autoantibodies","volume":"72","author":"Steck","year":"2016","journal-title":"J Autoimmun"},{"issue":"7","key":"2019101003033158400_bib33","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00125-013-2896-y","article-title":"Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children","volume":"56","author":"Achenbach","year":"2013","journal-title":"Diabetologia"},{"key":"2019101003033158400_bib34","article-title":"Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study [published online ahead of print 4 October 2018","author":"Beyerlein","journal-title":"J Med Genet"},{"issue":"2","key":"2019101003033158400_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/pedi.12545","article-title":"Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity","volume":"19","author":"Ilonen","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"2019101003033158400_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"issue":"10","key":"2019101003033158400_bib37","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00125-015-3672-y","article-title":"Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes","volume":"58","author":"Giannopoulou","year":"2015","journal-title":"Diabetologia"},{"issue":"6","key":"2019101003033158400_bib38","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s00125-018-4591-5","article-title":"Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study","volume":"61","author":"Long","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"2019101003033158400_bib39","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","article-title":"Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes","volume":"61","author":"Sioofy-Khojine","year":"2018","journal-title":"Diabetologia"},{"issue":"11","key":"2019101003033158400_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nri3755","article-title":"25-Hydroxycholesterols in innate and adaptive immunity","volume":"14","author":"Cyster","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2019101003033158400_bib41","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/eji.201747020","article-title":"EBI2 contributes to the induction of thymic central tolerance in mice by promoting rapid motility of medullary thymocytes","volume":"47","author":"Ki","year":"2017","journal-title":"Eur J Immunol"},{"issue":"11","key":"2019101003033158400_bib42","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes","volume":"63","author":"Arif","year":"2014","journal-title":"Diabetes"},{"issue":"8","key":"2019101003033158400_bib43","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s001250050770","article-title":"Antenatal risk factors for childhood diabetes mellitus; a case-control study of medical record data in Yorkshire, UK","volume":"40","author":"McKinney","year":"1997","journal-title":"Diabetologia"},{"issue":"12","key":"2019101003033158400_bib44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/14760584.2018.1548281","article-title":"Developing a vaccine for type 1 diabetes by targeting coxsackievirus B","volume":"17","author":"Hy\u00f6ty","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"2019101003033158400_bib45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/db13-0619","article-title":"Coxsackievirus B1 is associated with induction of \u03b2-cell autoimmunity that portends type 1 diabetes","volume":"63","author":"Laitinen","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"2019101003033158400_bib46","first-page":"381","article-title":"Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations","volume":"7","author":"Laron","year":"2005","journal-title":"Isr Med Assoc J"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/jc.2019-01069\/28938136\/jc.2019-01069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/11\/5585\/30124769\/jc.2019-01069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/11\/5585\/30124769\/jc.2019-01069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T03:36:39Z","timestamp":1721532999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/11\/5585\/5532586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-01069","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,7,17]]}}}